Single IRB vs Multiple IRBs: Multi-Site Study Guide

Single IRB vs Multiple IRBs: Multi-Site Study Guide

Multi-site clinical research has become increasingly common as investigators seek larger, more diverse participant populations to strengthen their findings. However, one of the most critical decisions researchers face is choosing between a single Institutional Review Board (IRB) or multiple IRBs for ethical oversight. This choice can significantly impact your study timeline, costs, and administrative complexity.

In this comprehensive guide, we'll explore the key differences between single and multiple IRB models, regulatory requirements, and practical considerations to help you make the best decision for your multi-site research.

Understanding the IRB Models for Multi-Site Research

The Multiple IRB Model: Traditional Approach

Historically, multi-site studies operated under a multiple IRB model, where each participating institution conducted its own independent ethical review. Under this approach:

• Each site's local IRB reviews the same protocol
• Each IRB applies its own institutional policies and interpretation of regulations
• Modifications must be submitted to and approved by each IRB separately
• Continuing reviews and adverse event reports are handled independently at each site

While this model provides local oversight and ensures institutional autonomy, it creates significant administrative burden and can lead to inconsistent implementation across sites.

The Single IRB Model: Streamlined Oversight

The single IRB (sIRB) model designates one IRB to serve as the reviewing body for all participating sites in a multi-site study. This centralized approach offers:

• One protocol review for all sites
• Consistent interpretation of ethical standards
• Streamlined amendment and continuing review processes
• Reduced administrative burden across the research enterprise
• Faster study activation timelines

The NIH Single IRB Mandate: What Changed

In 2016, the National Institutes of Health (NIH) issued a policy requiring single IRB review for all NIH-funded multi-site research in the United States involving non-exempt human subjects research. This mandate, effective January 25, 2018, fundamentally transformed how federally-funded multi-site studies approach IRB review.

The single IRB requirements include several key provisions:

• A single IRB of record must be selected to conduct the ethics review
• All participating sites must rely on this single IRB's determination
• The sIRB must have appropriate expertise and experience
• Local context considerations must still be addressed
• Documentation of the reliance arrangement must be maintained

It's important to note that this mandate applies specifically to NIH-funded research. However, many institutions and sponsors have adopted the sIRB model more broadly due to its efficiency benefits.

Comparing Single IRB vs Multiple IRBs: Key Considerations

Timeline and Study Activation

Multiple IRBs: - Review timelines vary by institution (typically 2-6 weeks per IRB) - Sites cannot activate until their local IRB approves - Study start dates can differ by months across sites - Total activation time: 3-12+ months depending on number of sites

Single IRB: - One review cycle for all sites - Simultaneous site activation possible after single approval - More predictable timelines - Total activation time: 1-3 months typically

For time-sensitive research, the single IRB model offers a clear advantage in getting studies up and running quickly.

Cost Implications

Multiple IRBs: - Initial review fees multiplied by number of sites - Continuing review fees at each institution - Amendment fees at each IRB - Higher administrative staff costs to manage multiple submissions - Potential total cost: $50,000-$500,000+ depending on study size and duration

Single IRB: - One initial review fee - One continuing review fee - Streamlined amendment costs - Reduced administrative overhead - Potential total cost: $10,000-$100,000 depending on complexity

The cost comparison between traditional and modern IRB approaches reveals significant potential savings with the centralized model, particularly for studies with numerous sites.

Administrative Complexity

Multiple IRBs: - Different submission requirements and forms at each site - Varying meeting schedules to track - Inconsistent feedback requiring protocol modifications that may not satisfy all IRBs - Managing different approval periods and renewal dates - Reconciling conflicting IRB decisions or requirements

Single IRB: - Standardized submission requirements across all sites - One set of communications to manage - Consistent interpretation and implementation - Aligned renewal dates - Single point of contact for questions

The reduction in administrative complexity is one of the most significant practical benefits of the sIRB model.

Scientific and Ethical Consistency

One often-overlooked advantage of the single IRB model is the consistency it brings to ethical oversight. When multiple IRBs review the same protocol, they may:

• Reach different conclusions about risk levels
• Require different consent language, creating confusion
• Mandate different monitoring requirements
• Interpret eligibility criteria differently

These inconsistencies can compromise study integrity and create challenges in data interpretation. A single IRB ensures uniform ethical standards and implementation across all sites.

When Multiple IRBs Might Still Make Sense

Despite the clear advantages of the sIRB model, there are situations where multiple IRBs may be appropriate or necessary:

International Multi-Site Studies

Research conducted across different countries often requires local ethical review to address: - Country-specific regulatory requirements - Cultural and community considerations - Local legal frameworks - Language and literacy differences

In these cases, a hybrid approach may work best, with one IRB for U.S. sites and local ethics committees for international locations.

Studies Not Covered by the NIH Mandate

Non-federally funded research, including: - Industry-sponsored trials that opt not to use sIRB - Privately funded academic research - Investigator-initiated studies at single institutions with affiliated sites

These studies may choose multiple IRBs if institutional policies require local review or if the research involves significant local context.

Institutional Requirements

Some institutions maintain policies requiring local IRB review for specific types of research, such as: - Studies involving vulnerable populations unique to that community - Research with significant local community engagement components - Trials involving institutional resources beyond typical clinical research

Practical Steps for Implementing Single IRB Review

1. Select the IRB of Record

Choose an IRB with: - Appropriate expertise in your research area - Experience serving as sIRB for multi-site studies - Capacity to handle your timeline requirements - Reasonable fee structure - Strong communication and responsiveness

For specialized research like medical device trials, ensure the sIRB has relevant technical expertise.

2. Establish Reliance Agreements

Each participating site must execute an authorization agreement or reliance agreement: - Documenting their agreement to rely on the sIRB's review - Clarifying responsibilities for local context review - Establishing communication protocols - Defining how site-specific information will be handled

Many institutions now use master reliance agreements or participate in platforms like SMART IRB to streamline this process.

3. Address Local Context Considerations

While the sIRB conducts the primary ethics review, participating sites retain responsibility for: - Ensuring the research is appropriate for their local population - Confirming adequate resources and facilities - Reviewing local recruitment materials and strategies - Assessing community-specific concerns - Verifying compliance with institutional policies not related to human subjects protection

4. Develop Communication Protocols

Establish clear processes for: - Sharing sIRB decisions with all sites - Collecting and reporting local adverse events to the sIRB - Submitting amendments that affect all sites vs. site-specific modifications - Conducting continuing review with input from all locations - Escalating concerns from participating sites

Common Challenges and Solutions

While the sIRB model offers numerous advantages, implementation isn't without challenges:

Challenge: Institutional Resistance

Some institutions hesitate to cede IRB authority to an external board.

Solution: Education about regulatory requirements, efficiency gains, and maintained institutional oversight through reliance agreements can help address concerns. Demonstrating successful sIRB studies can build confidence.

Challenge: Consent Form Variations

Sites may have different consent requirements based on state law or institutional policy.

Solution: Work with the sIRB to develop a core consent document with designated sections for site-specific customization. Clearly document what elements can be locally modified.

Challenge: Managing Site-Specific Modifications

Not all changes affect all sites equally.

Solution: Establish protocols for distinguishing between modifications requiring full sIRB review and those that are truly site-specific and can be handled locally.

Challenge: Different State Laws

Research regulations can vary by state jurisdiction.

Solution: The sIRB should have processes for identifying and addressing state-specific requirements. Site investigators must flag potential legal conflicts during local context review.

Making Your Decision: Key Questions

When deciding between single and multiple IRB review, consider:

1. Is your study subject to the NIH sIRB mandate? If yes, the decision is made for you.
2. How many sites are participating? The more sites, the greater the efficiency gains from sIRB.
3. What is your budget? Calculate the total cost difference between models.
4. How quickly do you need to activate sites? Urgent timelines favor sIRB.
5. Do participating institutions have experience with reliance agreements? Prior experience smooths implementation.
6. Are there significant local context differences across sites? If so, ensure robust local review processes supplement sIRB review.
7. What type of research are you conducting? Some study types benefit more from centralized expertise.

For most multi-site studies, particularly those with three or more sites, the single IRB model offers compelling advantages in timeline, cost, and consistency.

Moving Forward with Confidence

The shift toward single IRB review represents a significant improvement in how multi-site research is conducted. By reducing administrative burden, accelerating timelines, and ensuring consistent ethical oversight, the sIRB model allows researchers to focus on what matters most: conducting high-quality research that advances scientific knowledge and improves human health.

Whether you're planning your first multi-site study or looking to streamline your existing research portfolio, understanding the differences between single and multiple IRB models is essential for success.

Partner with Elemental IRB for Your Multi-Site Research

Navigating multi-site IRB review doesn't have to be complicated. Elemental IRB specializes in serving as the IRB of record for multi-site studies across diverse research areas. Our experienced team understands the unique challenges of coordinating ethics review across multiple institutions, and we're committed to providing efficient, high-quality oversight that keeps your research moving forward.

From expedited review for qualifying studies to full board review for complex protocols, we offer the expertise and responsiveness you need. Our transparent pricing and streamlined processes make us an ideal partner for academic institutions, startups, and established sponsors alike.

Contact Elemental IRB today to learn how we can support your multi-site research and help you achieve faster study activation, reduced costs, and consistent ethical oversight across all your participating sites.